Skip to main navigation
ZyVersa Therapeutics, Inc. logo
  • Overview
  • News & Events
    • News Releases
    • Events
    • Annual Meeting
    • ZyVersa in the News
    • Media Resources
  • Financials & Filings
    • Overview
    • All SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Presentations
    • Email Alerts
    • Contact IR

Media Resources

Media Resources

Corporate Media Contact

Karen Cashmere
Chief Commercial Officer
Office Phone: 754-231-1693
Mobile Phone: 786-251-9641
Kcashmere@zyversa.com

Media Resources

Corporate Logos
Management Team

Inflammasome Resources

Infographic: Inflammasome ASC Inhibitor, IC 100, MOA
White Paper: Inflammasomes, A Promising Therapeutic and Diagnostic Target
Video: Inflammasome ASC Inhibitor, IC 100, MOA

Renal Resources

Video: Renal Lipids And Kidney Disease
White Paper: Renal Lipids in the Pathogenesis of Kidney Disease
Print Page
Email Alerts
Contact IR
ZyVersa Therapeutics, Inc. logo
  • About
  • Inflammasomes
  • Renal Lipids
  • Pipeline
  • Careers
  • Investors & Media
  • Contact
  • ©2023 ZyVersa Therapeutics, Inc. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Trademarks
  • Sitemap